CBLL
CeriBell, Inc
NASDAQ: CBLL · HEALTHCARE · MEDICAL DEVICES
$20.16
+4.73% today
Updated 2026-04-30
Market cap
$802.14M
P/E ratio
—
P/S ratio
9.01x
EPS (TTM)
$-1.46
Dividend yield
—
52W range
$11 – $24
Volume
0.3M
CeriBell, Inc (CBLL) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $25.92M | $45.23M | $65.44M | $89.06M |
| Revenue growth (YoY) | — | +74.5% | +44.7% | +36.1% |
| Cost of revenue | $4.43M | $7.06M | $8.69M | $10.79M |
| Gross profit | $21.49M | $38.16M | $56.75M | $78.27M |
| Gross margin | 82.9% | 84.4% | 86.7% | 87.9% |
| R&D | $7.24M | $8.99M | $13.56M | $19.14M |
| SG&A | $18.46M | $20.29M | $33.84M | $44.45M |
| Operating income | $-36.02M | $-30.04M | $-39.71M | $-58.40M |
| Operating margin | -139.0% | -66.4% | -60.7% | -65.6% |
| EBITDA | $-35.06M | $-26.51M | $-37.32M | $-51.52M |
| EBITDA margin | -135.3% | -58.6% | -57.0% | -57.8% |
| EBIT | $-35.56M | $-27.36M | $-38.46M | — |
| Interest expense | $1.60M | $2.10M | $1.99M | $1.89M |
| Income tax | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-37.16M | $-29.46M | $-40.45M | $-53.41M |
| Net income growth (YoY) | — | +20.7% | -37.3% | -32.0% |
| Profit margin | -143.4% | -65.1% | -61.8% | -60.0% |